{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T16:29:36Z","timestamp":1748449776866},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2011,3,29]],"date-time":"2011-03-29T00:00:00Z","timestamp":1301356800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1007\/s00417-011-1667-z","type":"journal-article","created":{"date-parts":[[2011,3,28]],"date-time":"2011-03-28T10:26:41Z","timestamp":1301308001000},"page":"797-799","source":"Crossref","is-referenced-by-count":2,"title":["Orlans HO, Hornby SJ, Bowler IC (2011) In vitro antibiotic susceptibility patterns of bacterial keratitis isolates in Oxford, UK: a 10-year review. Eye Jan 21 [Epub ahead of print] PMID 21252952"],"prefix":"10.1007","volume":"249","author":[{"given":"Stephen","family":"Kaye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rose","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henri","family":"Sueke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Neal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,3,29]]},"reference":[{"key":"1667_CR1","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/00003226-200009000-00011","volume":"19","author":"J Baum","year":"2000","unstructured":"Baum J, Barza M (2000) The evolution of antibiotic therapy for bacterial conjunctivitis and keratitis: 1970\u20132000. Cornea 19:659\u2013672","journal-title":"Cornea"},{"key":"1667_CR2","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0002-9394(03)00294-0","volume":"136","author":"RP Kowalski","year":"2003","unstructured":"Kowalski RP, Dhaliwal DK, Karenchak LM, Romanowski EG, Mah FS, Ritterband DC, Gordon YJ (2003) Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates. Am J Ophthalmol 136:500\u2013505","journal-title":"Am J Ophthalmol"},{"key":"1667_CR3","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0002-9394(02)01334-X","volume":"133","author":"R Mather","year":"2002","unstructured":"Mather R, Karenchak LM, Romanowski EG, Kowalski RP (2002) Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics. Am J Ophthalmol 133:463\u2013466","journal-title":"Am J Ophthalmol"},{"key":"1667_CR4","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S0161-6420(99)00716-2","volume":"106","author":"MH Goldstein","year":"1999","unstructured":"Goldstein MH, Kowalski RP, Gordon YJ (1999) Emerging fluoroquinolone resistance in bacterial keratitis: a 5-year review. Ophthalmology 106:1313\u20131318","journal-title":"Ophthalmology"},{"key":"1667_CR5","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/S0161-6420(99)00717-4","volume":"106","author":"P Garg","year":"1999","unstructured":"Garg P, Sharma S, Rao GN (1999) Ciprofloxacin-resistant Pseudomonas keratitis. Ophthalmology 106:1319\u20131323","journal-title":"Ophthalmology"},{"key":"1667_CR6","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.jcrs.2007.04.015","volume":"33","author":"V Jhanji","year":"2007","unstructured":"Jhanji V, Sharma N, Satpathy G, Titiyal J (2007) Fourth-generation fluoroquinolone-resistant bacterial keratitis. J Cataract Refract Surg 33:1488\u20131489","journal-title":"J Cataract Refract Surg"},{"key":"1667_CR7","doi-asserted-by":"crossref","unstructured":"Orlans HO, Hornby SJ, Bowler IC (2011) In vitro antibiotic susceptibility patterns of bacterial keratitis isolates in Oxford, UK: a 10-year review. Eye Jan 21 [Epub ahead of print] PMID 21252952","DOI":"10.1038\/eye.2010.231"},{"key":"1667_CR8","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1167\/iovs.09-4638","volume":"51","author":"H Sueke","year":"2010","unstructured":"Sueke H, Kaye S, Neal T, Murphy C, Hall A, Whittaker D, Tuft S, Parry C (2010) Minimum inhibitory concentrations of standard and novel antimicrobials for isolates from bacterial keratitis. Invest Ophthalmol Vis Sci 51:2519\u20132524","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1667_CR9","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1001\/archopht.121.9.1229","volume":"121","author":"KR Wilhelmus","year":"2003","unstructured":"Wilhelmus KR, Abshire RL, Schlech BA (2003) Influence of fluoroquinolone susceptibility on the therapeutic response of fluoroquinolone-treated bacterial keratitis. Arch Ophthalmol 121:1229\u20131233","journal-title":"Arch Ophthalmol"},{"key":"1667_CR10","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ajo.2007.11.004","volume":"145","author":"A Chen","year":"2008","unstructured":"Chen A, Prajna L, Srinivasan M, Mahalakshmi R, Whitcher JP, McLeod S, Lietman TM, Acharya NR (2008) Does in vitro susceptibility predict clinical outcome in bacterial keratitis? Am J Ophthalmol 145:409\u2013412","journal-title":"Am J Ophthalmol"},{"key":"1667_CR11","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1167\/iovs.09-3933","volume":"51","author":"S Kaye","year":"2010","unstructured":"Kaye S, Tuft S, Neal T, Tole D, Leeming J, Figueiredo F, Armstrong M, McDonnell P, Tullo A, Parry C (2010) Bacterial susceptibility to topical antimicrobials and clinical outcome in bacterial keratitis. Invest Ophthalmol Vis Sci 51:362\u2013368","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1667_CR12","doi-asserted-by":"crossref","unstructured":"Sueke H, Kaye SB, Neal T, Hall A, Tuft S, Parry CM (2010) An in vitro investigation of synergy or antagonism between antimicrobial combinations against isolates from bacterial keratitis. Invest Ophthalmol Vis Sci 51(8):4151\u20134155","DOI":"10.1167\/iovs.09-4839"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-011-1667-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-011-1667-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-011-1667-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,9]],"date-time":"2019-06-09T13:30:17Z","timestamp":1560087017000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-011-1667-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,29]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["1667"],"URL":"https:\/\/doi.org\/10.1007\/s00417-011-1667-z","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,29]]}}}